JOHN VIERLING to Cholagogues and Choleretics
This is a "connection" page, showing publications JOHN VIERLING has written about Cholagogues and Choleretics.
Connection Strength
0.500
-
Primary biliary cholangitis. Lancet. 2024 09 14; 404(10457):1053-1066.
Score: 0.222
-
Future Treatment Options in PBC. Semin Liver Dis. 2005 Aug; 25(3):347-63.
Score: 0.059
-
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis. N Engl J Med. 2024 02 29; 390(9):783-794.
Score: 0.054
-
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis. N Engl J Med. 2024 02 29; 390(9):795-805.
Score: 0.053
-
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study. Hepatology. 2023 08 01; 78(2):397-415.
Score: 0.050
-
The challenges of primary biliary cholangitis: What is new and what needs to be done. J Autoimmun. 2019 12; 105:102328.
Score: 0.039
-
Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid. Hepatology. 2012 Feb; 55(2):512-21.
Score: 0.023